Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast

NCT: NCT05258305 · COMPLETED

NCT IDNCT05258305
StatusCOMPLETED
Start Date2022-05-05
Completion2025-01-08
SponsorTiger Biosciences, LLC. (INDUSTRY)
First posted
Last updated

Brief Summary

Prospective, multi-center, non-randomized, open-label, post-market clinical study evaluating adipose graft retention over time from lipoaspirate processed using the AuraGen 1-2-3™ with AuraClens™ Lipoaspirate Wash System.

Frequently Asked Questions

What is AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast?

AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast is a clinical trial registered under NCT05258305. Current status: COMPLETED.

What is the status of NCT05258305?

The current status of NCT05258305 (AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast) is: COMPLETED.

When did AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast start?

AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast started on 2022-05-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑